Obtained medical device certification for small models of medical HAL® in Europe
We have obtained medical device certification (*) that complies with the new European Medical Device Regulatio … 続きを読む
Preparations for the National Neurorobotic Cybernics Rehabilitation Centre of Malaysia are underway
On May 23, 2024, CYBERDYNE Co., Ltd. (Tsukuba City, Ibaraki Prefecture, President & CEO: Yoshiyuki Sankai, … 続きを読む
U.S. FDA Becomes the World’s First Approval for Smaller Models of Medical HAL® and Expanded Indications for Cerebral Palsy
CYBERDYNE Co., Ltd. (Tsukuba City, Ibaraki Prefecture, President: Yoshiyuki Sankai, hereinafter referred to as … 続きを読む
Initiation of an investigator-initiated clinical trial of BNCT using an accelerator for primary glioblastoma, an intractable brain tumor
The University of Tsukuba is pleased to announce the launch of Boron Neutron Capture Therapy, which uses an ac … 続きを読む
BNCT Clinical Trial “Phase I Clinical Trial for Primary Glioblastoma” has been released.
Click here for details (You will be redirected to an external site.) By Google Translate
June 2nd&3rd Tohoku Univ.& GREEN Joint Symposium (The 8th GREEN Symposium)
Tohoku Univ.& GREEN Joint Symposium (The 8th GREEN Symposium) The purpose of this symposium is to promote … 続きを読む
HAL is on the display at Tsukuba City Hall
HAL® is on the display at Tsukuba City Hall 1st floor. Please stop by Tsukuba City Hall and check it out! &nbs … 続きを読む
The Report: AAAS anual exihibition
Tsukuba International Strategic Zone participated in AAAS (American Association for Advanced Science) exhibiti … 続きを読む
Global Innovation Forum 2014
Joint Symposium of the Parliamentary Group on Science & Technology and Tsukuba Global Promotion Agency Glo … 続きを読む
Public Sidewalk Trials of Toyota Personal Mobility Robot to Start in Japan
The City of Tsukuba (Tsukuba) in Ibaraki Prefecture, Japan and Toyota Motor Corporation (TMC) are to begin pub … 続きを読む
